The expansion of NPIP and its associated SDs across the short arm of chromosome 16 predispose humans to frequent recurrent pathogenic duplications and deletions associated with autism, developmental delay, epilepsy, and obesity (6–10, 67–82). Here, NPIPA1 is linked to epilepsy.